Dex
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Dex, covering 2017-06-15 to 2022-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM [Phase 1, Phase 2]